Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-04-27 | We believe that Dr. Simon is qualified to serve as a member of our board of directors because of his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2017-04-28 | Dr. Simon has attended corporate training programs by the London School of Business and the Amos Tuck School of Business at Dartmouth College. He is clinically trained in infectious diseases, anesthesiology, and internal medicine and received his M.D. from the SUNY Downstate, Health Sciences Center in New York. |
| 2018-04-24 | We believe that Dr. Simon is qualified to serve as a member of our board of directors because of his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2019-04-26 | We believe that Dr. Simon is qualified to serve as a member of our board of directors because of his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2020-04-24 | We believe that Dr. Simon is qualified to serve as a member of our board of directors because of his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2021-04-29 | Dr. Simon trained clinically in Infectious Diseases at Albert Einstein College of Medicine, Anesthesiology at The Mount Sinai Medical Center and Internal Medicine at New York University and received his M.D. from the SUNY Downstate Health Sciences Center in New York. We believe that Dr. Simon is qualified to serve as a member of our board of directors because of his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2022-04-29 | Dr. Simon trained clinically in Infectious Diseases at Albert Einstein College of Medicine, Anesthesiology at The Mount Sinai Medical Center, and Internal Medicine at New York University and received his M.D. from the SUNY Downstate Health Sciences Center in New York. We believe Dr. Simon is qualified to serve as a member of the Board based on his extensive medical and scientific knowledge and experience, and senior management experience in the biopharmaceutical industry. |
| 2023-04-28 | Dr. Simon has extensive medical and scientific knowledge and senior management experience in the biopharmaceutical industry, with an M.D. from SUNY Downstate Health Sciences Center. |
| 2024-04-29 | Dr. Simon has broad experience in public and private settings, having led private and public equity offerings, product and portfolio divestitures and acquisitions, strategic licensing and joint ventures, as well as commercial product launches, investigational new drug and biologics license application regulatory filings, human-enabling programs, manufacturing, quality control and life cycle management. |
| Filing Date | Source Excerpt |
|---|---|
| 2022-04-27 | The following table sets forth the names, ages as of April 19, 2022, and certain other information for each of our directors and director nominees: Barry J. Simon, M.D., Director, Age 57, Director since 2021. Member of audit committee and compensation committee. Director Compensation table shows total compensation of $570,862. |
| 2023-04-27 | Dr. Simon has served as a member of the board of directors since March 2021. ... Member of audit committee, Member of compensation committee. Director Compensation: Barry J. Simon, M.D. - Total ($) 156,200. |
| 2024-04-26 | Dr. Simon has served as a member of the board of directors since March 2021. ... Dr. Simon trained clinically in Infectious Diseases at Albert Einstein College of Medicine, Anesthesiology at The Mount Sinai Medical Center and Internal Medicine at New York University and received his M.D. from the SUNY Downstate Health Sciences Center in New York. ... The following table sets forth information regarding the total compensation awarded to, earned by or paid to our non-employee directors for their service on our board of directors, for the fiscal year ended December 31, 2023. ... Barry J. Simon, M.D. Fees Paid or Earned in Cash ($) 65,000 Option Awards($) 45,755 Total ($) 110,755 ... The current members of our audit committee are Mr. Darcy, Dr. Rubino, and Dr. Simon. ... The current members of our compensation committee are Dr. Simon, Dr. Barlow, and Mr. Darcy. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25